A ranar 8 ga Mayu, 2022, Epiprobe ta ba da sanarwar cewa ta keɓance kayan aikin gano kwayoyin cutar kansa guda uku: TAGMe DNA Methylation Detection Kits (qPCR) don Ciwon Kan mahaifa, TAGMe DNA Methylation Detection Kits (qPCR) don Ciwon daji na Endometrial, TAGMe DNA Methylation Detection Kits (qPCR) ) don Ciwon Urothelial, sun sami takardar shedar EU CE kuma ana iya siyar da su a cikin ƙasashen EU da ƙasashen da aka sani CE.
Cikakken yanayin aikace-aikacen na'urorin gano methylation na DNA guda uku
Kayan aiki guda uku na sama sun dace daidai da injunan qPCR na yau da kullun akan kasuwa.Ba sa buƙatar magani na bisulfite, yana sa tsarin ganowa ya zama mai sauƙi da dacewa.Alamar methylation guda ɗaya mai dacewa ga kowane nau'in ciwon daji na kowa.
Yanayin aikace-aikacen TAGMe DNA Methylation Kits (qPCR) don Ciwon daji na Cervical ciki har da:
● Yin gwajin cutar kansar mahaifa ga mata masu shekaru sama da 30
● Ƙimar haɗari ga mata masu HPV
● Ƙwararren bincike na ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar ƙwayar cuta da adenocarcinoma
● Kulawa da sake dawowa bayan tiyata na ciwon daji na mahaifa
Yanayin aikace-aikacen TAGMe DNA Methylation Kits (qPCR) don Ciwon daji na Endometrial ciki har da:
● Bincike don ciwon daji na endometrial tsakanin yawan jama'a masu haɗari
● Cika rata a cikin binciken kwayoyin cutar kansar endometrial
● Kulawa da sake dawowa bayan tiyata na ciwon daji na endometrial
Yanayin aikace-aikacen TAGMe DNA Methylation Kits (qPCR) don Ciwon daji na Urothelial ciki har da:
● Auna cutar kansar urothelial tsakanin jama'a masu haɗari
● Gwajin cystoscopy na waje
● Ƙididdigar sakamakon maganin tiyata a cikin marasa lafiya da ciwon daji na mafitsara
● Ƙididdigar chemotherapy a cikin marasa lafiya da ciwon daji na mafitsara
● Kulawa da sake dawowa bayan tiyata don ciwon daji na urothelial
Tsarin Epiprobe'globalization yana ci gaba da sauri, kuma samfuran sun wuce Takaddar CE ta Tarayyar Turai.
A halin yanzu, Epiprobe ya kafa ƙwararrun ƙungiyar rajista.
A halin yanzu, haɗe tare da sababbin buƙatun don binciken alamomin pan-cancer da ganewar asali, Epiprobe ya ci gaba da haɓaka nau'in samfuri da haɓakar R&D.Tun da na'urorin gano kwayoyin cutar kansa guda uku sun sami takardar shedar EU CE, yana nuna cewa waɗannan samfuran sun dace da EU in vitro diagnostic reagent na'urar likitancin da ke da alaƙa da umarnin, kuma ana iya siyar da su a cikin ƙasashe membobin EU da ƙasashen da ke amincewa da takardar shedar EU CE.Wannan zai ƙara haɓaka layin samfuran kamfanin na duniya, haɓaka gasa gabaɗaya, da kuma kammala tsarin kasuwancin sa na duniya.
Madam Hua Lin, Shugabar Epiprobe ta lura cewa:
Tare da ƙoƙarin haɗin gwiwar rajista na kamfani, R&D, gudanarwa mai inganci, tallace-tallace da sauran sassan, Epiprobe ya sami takardar shedar EU CE na samfuran gano cutar kansar mahaifa, ciwon daji na endometrial, da kansar urothelial.Godiya ga waɗannan ƙoƙarce-ƙoƙarce, an faɗaɗa yankin tallace-tallace na Epiprobe zuwa Tarayyar Turai da yankuna masu alaƙa, wanda ke ɗaukar matakai mai ƙarfi don tabbatar da tsarin tallace-tallace na duniya na samfuran kamfanin."Epiprobe zai bunkasa kasuwannin duniya sosai don gwajin ciwon daji na farko, da kuma ci gaba da kasuwanni da tashoshi na kasa da kasa, ya dogara da tsarin gudanarwa da tsarin rajista, hanyoyin gudanarwa na duniya da kuma fasahar gano methylation, ta amfani da mafi yawan fasaha da samfurori don taimakawa mutanen duniya. , amfanin duniya lafiya.
Game da CE
Alamar CE tana nufin haƙƙin haƙƙin takaddun takaddun samfur na ƙasashen EU.Alamar CE tana nuna cewa samfuran sun dace da ƙa'idodin ƙa'idodin Turai waɗanda suka dace akan lafiya, aminci, kariyar muhalli da kariyar mabukaci, kuma waɗannan samfuran ana iya samun damar shiga cikin doka da rarraba su a cikin kasuwar EU guda ɗaya.
Game da Epiprobe
An kafa shi a cikin 2018, Epiprobe, a matsayin mai ɗaukaka kuma majagaba na farkon gwajin cutar kansa, babban kamfani ne na fasaha wanda ke mai da hankali kan gano ƙwayoyin ƙwayoyin cuta na kansa da ingantattun masana'antar magunguna.Gina kan ƙwararrun ƙwararrun ƙwararrun ƙwararrun epigenetics da tarin ilimi mai zurfi, Epiprobe ya bincika fagen gano cutar kansa, yana ba da hangen nesa na "tsare kowa daga cutar kansa," wanda ya himmatu wajen gano wuri, gano wuri da wuri da maganin ciwon daji, wanda zai inganta. yawan tsira da masu fama da ciwon daji da inganta lafiyar mutane baki daya.
Lokacin aikawa: Mayu-08-2022